IP Library Granted Patent US 12,419,808
Granted Patent B2
US 12,419,808 · App. 17/588,666 · Granted Sep 23, 2025

Vial closure for rehydrating medication

Inventor: Cory Price (Newport Beach, CA)
Assignee: VIANT MEDICAL, LLC
A61J1/2089A61J1/1418A61J1/201A61J1/2096A61J1/065A61J1/2093
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,419,808
App. No.
17/588,666
Granted
Sep 23, 2025
Kind
B2
Abstract

A vial cap is configured to releasably contain a portion of a material, for example a powdered medication, for dispensing into a container. Via operation of a depressable plunger, the material is released into the container for rehydrating and mixing with a liquid, and thereafter may be extracted, such as via a needle. In this manner, a rehydrated medication may be provided in a predetermined amount and at a desired time.

Claims (30)

1. A cap for a container holding a liquid, the cap comprising:

a cap body comprising a durable material, the cap body comprising a radially inner surface that at least partially defines a space for containing an anhydrous material, the cap body further comprising a thread configured to couple to a vial;

a depressable plunger coupled to the cap body, the depressable plunger comprising:

a tubular element extending from a first end to a second end and at least partially defining a longitudinal axis, the tubular element comprising a radially outer surface;

a first flange extending radially outward from the radially outer surface,

a second flange extending radially outward from the radially outer surface, the second flange spaced apart longitudinally from the first flange, the second flange comprising an annular groove disposed therein, and

an extended portion that extends longitudinally from the second flange and away from the first flange, the extended portion configured to release the anhydrous material into the liquid when the depressable plunger is depressed,

wherein the depressable plunger is longitudinally contained within the cap body;

a flexible O-ring operable as a seal for the depressable plunger, the flexible O-ring disposed at least partially within the annular groove of the second flange, the flexible O-ring disposed radially between the radially inner surface of the cap body and the annular groove; and

a septum disposed at least partially within the depressable plunger, the septum operable to permit a needle to pass therethrough to access the liquid;

wherein the flexible O-ring and the septum are monolithic; and

wherein the flexible O-ring and the septum are separate unit with the depressable plunger.

2. The cap of claim 1 , wherein the depressable plunger is positioned radially inward of protected from accidental activation by being at least partially contained within the cap body.

3. The cap of claim 1 , further comprising a releasable agitator disposed in the space for containing the anhydrous material.

4. The cap of claim 1 , wherein the anhydrous material is a medication that must be administered intravenously.

5. The cap of claim 1 , wherein the depressable plunger comprises a heel that forces a portion of a membrane into an opened position, and wherein the membrane at least partially surrounds the anhydrous material.

6. The cap of claim 1 , wherein the cap body is configured to lock the depressable plunger into a depressed position in response to depressing the depressable plunger.

7. The cap of claim 1 , wherein the septum and the flexible O-ring are configured to seal an internal cavity of the vial from an external environment in response to coupling the cap to the vial.

8. The cap of claim 1 , further comprising the anhydrous material disposed within the cap body.

9. The cap of claim 8 , further comprising a membrane spaced apart longitudinally from the second flange, wherein the anhydrous material is disposed longitudinally between the second flange and the membrane.

10. The cap of claim 9 , further comprising an agitator disposed longitudinally between the septum and the membrane.

11. The cap of claim 9 , further comprising a score disposed in the membrane.

12. The cap of claim 11 , wherein the score is configured to facilitate perforation of the membrane in response to the depressable plunger being depressed and the extended portion piercing the score.

13. The cap of claim 1 , wherein:

the cap body comprises a first snap feature spaced apart longitudinally from a second snap feature,

the first snap feature comprising a first aperture disposed in the radially inner surface of the cap body, and

the second snap feature comprising a second aperture disposed in the radially inner surface of the cap body.

14. The cap of claim 13 , further comprising a pre-activated configuration and an activated configuration, wherein:

the pre-activated configuration comprises the first flange snapped into the first snap feature, and

the activated configuration comprises the first flange snapped into the second snap feature.

Assignments (3)
SECOND LIEN PATENT SECURITY AGREEMENT Recorded Nov 1, 2024
From: VIANT MEDICAL, LLC (F/K/A MEDPLAST, LLC)
To: HPS INVESTMENT PARTNERS, LLC, AS COLLATERAL AGENT
Reel/Frame 069288/0939 →
SECURITY INTEREST Recorded Oct 31, 2024
From: VIANT MEDICAL, LLC
To: UBS AG, STAMFORD BRANCH
Reel/Frame 069094/0187 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2022
From: PRICE, CORY
To: VIANT MEDICAL, LLC
Reel/Frame 058829/0542 →
Continuity (3)
Division 16117177 · Aug 30, 2018
Provisional Application 62552136 · Aug 30, 2017
Related Publication 20220151874A1 · May 19, 2022
References Cited (26)
US 2487236A · Greenberg · 1949 [cited by examiner]
US 3156369A · Bowes · 1964 [cited by examiner]
US 3603469A · Magni · 1971 [cited by examiner]
US 3651990A · Cernei · 1972 [cited by examiner]
US 3840136A · Lanfranconi · 1974 [cited by examiner]
US 4195731A · Cavazza · 1980 [cited by examiner]
US 6568439B1 · Se · 2003 [cited by examiner]
US 6840373B2 · Gibler · 2005 [cited by examiner]
US 7025200B2 · Fontana · 2006 [cited by examiner]
US 7249690B2 · Smith · 2007 [cited by examiner]
US 7325676B2 · Galaz Rodriguez · 2008 [cited by examiner]
US 7503453B2 · Cronin · 2009 [cited by examiner]
US 7748550B2 · Cho · 2010 [cited by examiner]
US 7854104B2 · Cronin · 2010 [cited by examiner]
US 7951109B2 · Anderson · 2011 [cited by examiner]
US 8167155B2 · Hsieh · 2012 [cited by examiner]
US 8387786B2 · Fontana · 2013 [cited by examiner]
US 8418865B2 · Cho · 2013 [cited by examiner]
US 8783452B2 · Thoman · 2014 [cited by examiner]
US 8844715B2 · Lee · 2014 [cited by examiner]
US 11246802B2 · Tsakas · 2022 [cited by examiner]
US 20040226835A1 · Takahashi · 2004 [cited by examiner]
US 20060108314A1 · Cho · 2006 [cited by examiner]
US 20090057262A1 · Cho · 2009 [cited by examiner]
US 20090139951A1 · Chen · 2009 [cited by examiner]
US 20170258683A1 · Tsakas · 2017 [cited by examiner]